Home Health UBS' Fowler Sees Value in US Cyclicals, Pharmaceuticals
Health

UBS' Fowler Sees Value in US Cyclicals, Pharmaceuticals

Key Points

Jun 24th, 2026 UBS' Fowler Sees Value in US Cyclicals, Pharmaceuticals UBS Chief European Equity Strategist and Head of Derivates Gerry Fowler discusses the factors behind the tech selloff and where he sees value in markets. "You're going to get volatility — this isn't the first time we've seen this," Fowler tells Bloomberg Television. "It's an artifice of market structure that I suspect is not going away."

Jun 24th, 2026 UBS' Fowler Sees Value in US Cyclicals, Pharmaceuticals UBS Chief European Equity Strategist and Head of Derivates Gerry Fowler discusses the factors behind the tech selloff and where he sees value in markets. "You're going to get volatility — this isn't the first time we've seen this," Fowler tells Bloomberg Television. "It's an artifice of market structure that I suspect is not going away."
UBS (ORG) US (LOCATION) Pharmaceuticals UBS (ORG) European Equity (ORG) Derivates (ORG) Gerry Fowler (PERSON) Fowler (PERSON) Bloomberg Television (ORG)
Originally published by Bloomberg Technology Read original →